
Contact us
About company
AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
Unknown
Unknown
Not verified company

AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.